The partnership with BARDA and JPEO-CBRND includes a $20 million investment for increased syringe and needle device production to support Operation Warp Speed vaccine program.

Smiths Medical is aware of, and currently monitoring, the Cybersecurity and Infrastructure Security Agency (CISA) notification concerning the Cybersecurity Vulnerability, ICSA-20-168-01